Increased constriction of the ductus arteriosus by dexamethasone, indomethacin, and rofecoxib in fetal rats

Circulation Journal

Volumn 69, Issue 3, 2005, Pages 354-358

  Takami, Takeshi ^a   Momma, Kazuo ^b   Imamura, Shinichiro ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2 inhibitor; Dexamethasone; Indomethacin; Patent ductus arteriosus

Indexed keywords

DEXAMETHASONE; INDOMETACIN; ROFECOXIB;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG POTENTIATION; DUCTUS ARTERIOSUS; FETUS; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PULMONARY ARTERY; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; DUCTUS ARTERIOSUS; DUCTUS ARTERIOSUS, PATENT; FETUS; INDOMETHACIN; LACTONES; MODELS, ANIMAL; RATS; RATS, WISTAR; SULFONES; VASOCONSTRICTION;

EID: 15744383390     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.354     Document Type: Article

References (21)

1. nd edn. New York: Futura; 2001; 155-196.
2. th edn. Philadelphia: Lippincott Williams & Wilkins; 1999; 445-472.
3. nd edn. Baltimore: Williams & Wilkins; 1998; 2489-2514.
4. Watanabe K, Tomita H, Ono Y, Yamada O, Kurosaki K, Echigo S. Intravenous indomethacin therapy in infants with a patent ductus arteriosus complicating other congenital heart defect. Circ J 2003; 67: 750-752.
5. Momma K, Nishihara S, Ota Y. Constriction of the fetal ductus arteriosus by glucocorticoid hormones. Pediatr Res 1981; 15: 19-21.
6. Heyman E, Ohlsson A, Shennan AT, Heilbut M, Coceani F. Closure of patent ductus arteriosus alter treatment with dexamethasone. Acta Paediatr Scand 1990; 79: 698-700.
7. Morales P, Rastogi A, Bez ML, Akintorin SM, Pyati S, Andes SM, et al. Effect of dexamethasone therapy on the neonatal ductus arteriosus. Pediatr Cardiol 1998; 19: 225-229.
8. Vane JR, Botting RM. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104: 2s-8s.
9. Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomized double-blind comparison. Lancet 1999; 354: 2106-2111.
10. Bolten WW. Scientific rationale for specific inhibition of COX-2. J Rheumatol 1998; 25(Suppl 51): 2-7.
11. Clyman RI, Hardy P, Waleh H, Chen YQ, Mauray F, Fouron JC, et al. Cyclooxygenase-2 plays a significant role in regulating the tone of the fetal lamb ductus arteriosus. Am J Physiol 1999; 276: R913-R921.
12. Clyman RI, Mauray F, Roman C, Rudolph AM. Glucocorticoids alter the sensitivity of the ductus arteriosus to prostaglandin E2. J Pediatr 1981; 98: 126-128.
13. Flower DJ, Blackwell GJ. Anti-inflammatory steroid induce biosyn-thsis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 1979; 278: 456-459.
14. Kuehl FA, Egan RW. Prostaglandins, arachidonic acid, and inflammation. Science 1980; 210: 978-984.
15. Chan C-C, Boyce S, Brideau C, Ford-Hutchinson AW, Gordon R, Guay D, et al. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: A novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 1995; 274: 1531-1537.
16. Futaki N, Yoshikawa K, Hamasaka Y, Arai I, Higuchi S, Iizuka H, et al. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmacol 1993; 24: 105-110.
17. Gans KR, Galbraith W, Roman RJ, Haber SB, Kerr JS, Schmidt WK, et al. Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor. J Pharmacol Exp Ther 1990; 254: 180-187.
18. Takahashi Y, Roman C, Chemtob S, Tse MM, Lin E, Heymann MA, et al. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol Regulatory Integrative Comp Physiol 2000; 278: R1496-R1505.
19. Clyman RI, Hardy P, Waleh N, Chen YQ, Mauray F, Fouron J-C, et al. Cyclooxygenase-2 plays a significant role in regulating the tone of the fetal lamb ductus arteriosus. Am J Physiol Regulatory Integrative Comp Physiol 1999; 276: R913-R921.
20. Momma K, Toyono M. The role of nitric oxide in dilating the fetal ductus arteriosus in rats. Pediatr Res 1999; 46: 311-315.
21. Yallampalli C, Byamsmith M, Nelson SO, Garfield RE. Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology 1994; 134: 1971-1974.